Skip to content
Home - Partnering - Key areas of partnering interest    
AstraZeneca in Japan

AstraZeneca highly values the discovery research and drug development activities being performed in Japan. Through strategic alliances, licensing and R&D collaborations
AstraZeneca in Japan contributes to develop innovative drugs and can thereby help improve people’s lives globally.

Our representatives in Japan act as contacts for the following alliance activities, and we are also seeking in-licensing oppor-tunities (especially oncology) for the Japanese territory

Key areas of partnering interest

Pharmaceutical and Biotechnology companies
- Research collaborations for discovery
- Licensing compounds and products (global and/or Japan)
- Technology Transfer

Academia
- Research collaborations for discovery
- Technology Transfer 

Contact information
For your first contact, please send an e-mail to
biotech.transfer.japan@astrazeneca.com

Iku Sugioka, Licensing compounds and products
Masaki Nakanishi, Licensing compounds and products
Motonori Yamaguchi, Research collaborations and technology transfer 
Akiko Hiraide, Research collaborations and technology transfer

E-mail:
firstname.lastname@astrazeneca.com
- Replace with authentic names

AstraZeneca websites
Search